House committees in the US capital plan to begin voting on the replacement of the Affordable Care Act (ACA) on Wednesday.
The ACA, or Obamacare, was introduced by the previous President Barack Obama and has been credited for helping more than 20 million formerly uninsured Americans to access health insurance.
But increases in insurance premiums have been blamed on Obamacare and new President Donald Trump has been highly critical of the policy and promised to replace it.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze